Document is current
Any future updates will be listed below
-
Authors
Szarzanowicz, Matthew J. https://orcid.org/0009-0003-4398-5196
Waldburger, Lucas M.
Busche, Michael https://orcid.org/0000-0001-8845-3300
Geiselman, Gina M.
Kirkpatrick, Liam D. https://orcid.org/0000-0002-2744-9102
Kehl, Alexander J.
Tahmin, Claudine
Kuo, Rita C.
McCauley, Joshua https://orcid.org/0000-0002-3766-560X
Pannu, Hamreet
Cui, Ruoming
Liu, Shuying
Hillson, Nathan J. https://orcid.org/0000-0002-9169-3978
Brunkard, Jacob O. https://orcid.org/0000-0001-6407-9393
Keasling, Jay D. https://orcid.org/0000-0003-4170-6088
Gladden, John M.
Thompson, Mitchell G. https://orcid.org/0000-0002-1490-8074
Shih, Patrick M. https://orcid.org/0000-0002-2119-3345
-
Funding
Funding for this research was provided by:
U.S. Department of Energy (DE-AC02-05CH11231)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 7 May 2024
Accepted: 2 October 2024
First Online: 4 November 2024
Competing interests
: A patent on optimal copy number binary vectors has been filed by Lawrence Berkeley National Laboratory with M.G.T., M.J.S., L.D.K., L.M.W. and P.M.S. as inventors. J.D.K. has financial interests in Amyris, Ansa Biotechnologies, Apertor Pharma, Berkeley Yeast, BioMia, Demetrix, Lygos, Napigen, ResVita Bio and Zero Acre Farms. N.J.H. has financial interests in TeselaGen Biotechnologies and Ansa Biotechnologies. The other authors declare no competing interests.
